RACHEL WESTERBECK: Open Payments
NPI 1619576253 · DUBLIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,581 in 95 payments from 15 companies in 2025. Trend: 2023 $1,000 · 2024 $1,682 · 2025 $1,581
Food & beverage: $1,581
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $438 |
| GENZYME CORPORATION | 7 | $264 |
| Janssen Biotech, Inc. | 18 | $208 |
| UCB, Inc. | 22 | $137 |
| Regeneron Healthcare Solutions, Inc. | 5 | $126 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| Incyte Corporation | 4 | $70 |
| Lilly USA, LLC | 2 | $60 |
| Organon LLC | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
Products named: DUPIXENT, RINVOQ, TREMFYA, SKYRIZI, Bimzelx, COSENTYX, OPZELURA, Sotyktu.
Industry payments across GA — which companies pay providers there.
